Launmer Ulgn-Tomes
FDA investigator
Appears on 1 document from 2019, mostly at sites in China. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2019
- First seen
- 2019
- Most recent
What they cite most
From 4 observations- 21 CFR 211.160General requirements3
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2019: 1
Where
China 1
Is Launmer Ulgn-Tomes coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-04-26 | 483 Bloomage Biotechnology corp., Ltd.Apr 26, 2019 · Jinan, China | Jinan, China | 4 |
About this profile
What does Launmer Ulgn-Tomes inspect?
Launmer Ulgn-Tomes appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Launmer Ulgn-Tomes is dated Apr 26, 2019.